Overview

Effect of Evolocumab on Coronary Endothelial Function

Status:
Completed
Trial end date:
2019-11-30
Target enrollment:
Participant gender:
Summary
The investigators propose a pilot study using (1) MRI to assess coronary artery endothelial function, (2) brachial ultrasound to assess systemic endothelial function, (3) serum markers of inflammation and of endothelial cell function and (4) echocardiographic measures of left ventricular diastolic and systolic properties, before and following initiation of PCSK9 antibody in HIV positive subjects.
Phase:
Phase 2
Details
Lead Sponsor:
Johns Hopkins University
Collaborator:
American Heart Association
Treatments:
Antibodies, Monoclonal
Evolocumab